VIRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.69%

Insider Buying (Last 12 Months): $25,526.06

Insider Selling (Last 12 Months): $4,345.65

Viracta Therapeutics Insider Trading History Chart

Viracta Therapeutics Share Price & Price History

^$0.15

+0.30 (1.20%)

As of 11/21/2024 06:38 PM ET

Days: 30 | 90 | 365

JD Vance Predicts: Wall Street vs. Trump & Your Money

From Priority Gold | Ad

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

Viracta Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/27/2024	Daniel R. Chevallard	CFO	Sell	3,405	$0.73	$2,485.65	102,306
11/30/2023	Mark Rothera	CEO	Buy	52,094	$0.49	$25,526.06	52,094
11/28/2023	Daniel R. Chevallard	CFO	Sell	3,720	$0.50	$1,860.00	98,822
8/28/2023	Daniel R. Chevallard	CFO	Sell	3,512	$1.45	$5,092.40	95,653
5/25/2023	Daniel R. Chevallard	CFO	Sell	3,635	$1.42	$5,161.70	92,277
2/27/2023	Daniel R. Chevallard	CFO	Sell	3,599	$1.68	$6,046.32	89,023
2/27/2023	Lisa Rojkjaer	Insider	Sell	2,156	$1.68	$3,622.08	48,087
11/28/2022	Daniel R. Chevallard	CFO	Sell	3,532	$2.72	$9,607.04	85,733
11/28/2022	Lisa Rojkjaer	Insider	Sell	2,116	$2.72	$5,755.52	46,116
8/26/2022	Daniel R. Chevallard	CFO	Sell	3,655	$4.02	$14,693.10	82,376
8/26/2022	Ivor Royston	CEO	Sell	13,379	$4.01	$53,649.79	612,770
8/26/2022	Lisa Rojkjaer	Insider	Sell	2,190	$4.01	$8,781.90	44,105
5/26/2022	Daniel R. Chevallard	CFO	Sell	3,596	$1.90	$6,832.40	79,142
5/26/2022	Ivor Royston	CEO	Sell	13,162	$1.90	$25,007.80	600,930
5/26/2022	Lisa Rojkjaer	Insider	Sell	2,154	$1.90	$4,092.60	42,168
2/28/2022	Daniel R. Chevallard	CFO	Sell	3,998	$2.78	$11,114.44
2/28/2022	Ivor Royston	CEO	Sell	14,635	$2.78	$40,685.30
2/28/2022	Lisa Rojkjaer	Insider	Sell	2,395	$2.78	$6,658.10
11/29/2021	Daniel R. Chevallard	CFO	Sell	4,325	$4.82	$20,846.50
11/29/2021	Ivor Royston	CEO	Sell	15,833	$4.82	$76,315.06
11/29/2021	Lisa Rojkjaer	Insider	Sell	2,591	$4.82	$12,488.62
11/26/2021	Daniel R. Chevallard	CFO	Sell	3,254	$4.80	$15,619.20
11/26/2021	Ivor Royston	CEO	Sell	11,914	$4.80	$57,187.20
11/26/2021	Lisa Rojkjaer	Insider	Sell	1,950	$4.80	$9,360.00

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

From Darwin | Ad

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

SEC Filings (Institutional Ownership Changes) for Viracta Therapeutics (NASDAQ:VIRX)

31.37% of Viracta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Viracta Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Stonepine Capital Management LLC	500,000	$0.12M	0.1%	N/A	1.268%
11/13/2023	Acadian Asset Management LLC	97,109	$99K	0.0%	-42.1%	0.252%
8/7/2023	Acadian Asset Management LLC	167,818	$0.24M	0.0%	+74.6%	0.436%
8/2/2023	MAI Capital Management	307,570	$0.43M	0.0%	-18.9%	0.800%
7/20/2023	Bailard Inc.	47,700	$67K	0.0%	+139.7%	0.124%
5/15/2023	Rubric Capital Management LP	1,487,385	$2.37M	0.1%	+11.8%	3.872%
5/10/2023	MAI Capital Management	379,468	$0.60M	0.0%	-11.1%	0.988%
5/8/2023	Bailard Inc.	19,900	$32K	0.0%	N/A	0.052%
4/4/2023	Trust Co. of Toledo NA OH	28,000	$45K	0.0%	N/A	0.073%
2/9/2023	MAI Capital Management	426,916	$0.62M	0.0%	-33.0%	1.118%
11/14/2022	Ergoteles LLC	132,636	$0.57M	0.0%	-14.7%	0.353%
11/14/2022	Rubric Capital Management LP	994,801	$4.25M	0.2%	N/A	2.649%
11/8/2022	Hamilton Lane Advisors LLC	35,791	$0.15M	0.1%	-49.9%	0.095%
8/15/2022	Laurion Capital Management LP	698,000	$2.71M	0.0%	N/A	1.858%
8/12/2022	Ensign Peak Advisors Inc	63,406	$0.25M	0.0%	+4.8%	0.169%
7/20/2022	Clear Harbor Asset Management LLC	25,000	$97K	0.0%	N/A	0.067%
7/19/2022	MAI Capital Management	647,950	$2.51M	0.0%	+70.2%	1.728%
5/11/2022	Veritable L.P.	24,836	$0.12M	0.0%	N/A	0.066%
5/10/2022	MAI Capital Management	380,788	$1.81M	0.0%	N/A	1.016%
2/25/2022	AlphaCentric Advisors LLC	90,000	$0.33M	0.1%	N/A	0.241%
2/11/2022	Ensign Peak Advisors Inc	60,515	$0.22M	0.0%	N/A	0.162%
2/8/2022	ProShare Advisors LLC	13,174	$49K	0.0%	N/A	0.035%
2/8/2022	Northern Trust Corp	293,492	$1.07M	0.0%	-2.8%	0.787%
1/28/2022	Allspring Global Investments Holdings LLC	73,011	$0.27M	0.0%	N/A	0.196%
11/16/2021	Janus Henderson Group PLC	249,686	$2M	0.0%	-20.4%	0.669%
11/16/2021	Metropolitan Life Insurance Co NY	5,766	$46K	0.0%	-48.8%	0.015%
11/15/2021	Royal Bank of Canada	182,319	$1.46M	0.0%	-6.3%	0.490%
11/15/2021	Franklin Resources Inc.	43,618	$0.35M	0.0%	N/A	0.117%
11/15/2021	Jasper Ridge Partners L.P.	92,939	$0.75M	0.0%	N/A	0.250%
11/12/2021	Jump Financial LLC	21,852	$0.18M	0.0%	N/A	0.059%
11/12/2021	Oppenheimer & Co. Inc.	38,037	$0.31M	0.0%	N/A	0.102%
11/12/2021	Geode Capital Management LLC	481,301	$3.86M	0.0%	+7.1%	1.293%
11/10/2021	Goldman Sachs Group Inc.	171,194	$1.37M	0.0%	-34.5%	0.460%
11/10/2021	Citigroup Inc.	4,206	$34K	0.0%	+109.6%	0.011%
11/9/2021	Bourgeon Capital Management LLC	18,750	$0.15M	0.0%	+3,650.0%	0.050%
11/9/2021	BlackRock Inc.	2,085,048	$16.72M	0.0%	+1.2%	5.600%
11/8/2021	State Board of Administration of Florida Retirement System	10,068	$81K	0.0%	N/A	0.027%
11/5/2021	Advisor Group Holdings Inc.	4,999	$39K	0.0%	N/A	0.013%
11/2/2021	New York State Common Retirement Fund	22,055	$0.18M	0.0%	-28.9%	0.059%
11/1/2021	SG Americas Securities LLC	20,454	$0.16M	0.0%	N/A	0.055%
10/22/2021	Spire Wealth Management	3,698	$30K	0.0%	-48.1%	0.010%
10/14/2021	Hamilton Lane Advisors LLC	71,491	$0.57M	0.1%	N/A	0.192%
8/17/2021	Samsara BioCapital LLC	711,039	$8.06M	1.0%	-14.5%	1.917%
8/17/2021	Metropolitan Life Insurance Co NY	11,260	$0.13M	0.0%	N/A	0.030%
8/17/2021	MetLife Investment Management LLC	14,707	$0.17M	0.0%	N/A	0.040%
8/17/2021	Bridgeway Capital Management LLC	50,000	$0.57M	0.0%	N/A	0.135%
8/16/2021	Opaleye Management Inc.	257,189	$2.92M	0.5%	+148.3%	0.693%
8/16/2021	California State Teachers Retirement System	49,982	$0.57M	0.0%	N/A	0.135%
8/16/2021	Kettle Hill Capital Management LLC	185,065	$2.10M	0.4%	N/A	0.499%
8/16/2021	Royal Bank of Canada	194,526	$2.21M	0.0%	+9,426.2%	0.524%
8/16/2021	Charles Schwab Investment Management Inc.	83,792	$0.95M	0.0%	N/A	0.226%
8/16/2021	State Street Corp	484,222	$5.49M	0.0%	N/A	1.305%
8/16/2021	Nuveen Asset Management LLC	147,734	$1.68M	0.0%	N/A	0.398%
8/16/2021	Goldman Sachs Group Inc.	261,513	$2.97M	0.0%	-56.7%	0.705%
8/13/2021	Northern Trust Corp	313,350	$3.55M	0.0%	+2,273.5%	0.845%
8/13/2021	QS Investors LLC	43,618	$0.50M	0.0%	N/A	0.118%
8/13/2021	Geode Capital Management LLC	449,236	$5.09M	0.0%	+667.5%	1.211%
8/13/2021	Vanguard Group Inc.	1,433,922	$16.26M	0.0%	+589.2%	3.866%
8/13/2021	Bailard Inc.	145,000	$1.64M	0.1%	+291.9%	0.391%
8/12/2021	Trexquant Investment LP	10,339	$0.12M	0.0%	N/A	0.028%
8/12/2021	Legal & General Group Plc	3,098	$35K	0.0%	N/A	0.008%
8/12/2021	JPMorgan Chase & Co.	13,919	$0.16M	0.0%	N/A	0.038%
8/12/2021	The Manufacturers Life Insurance Company	21,875	$0.25M	0.0%	N/A	0.059%
8/11/2021	Bank of New York Mellon Corp	98,295	$1.12M	0.0%	N/A	0.265%
8/11/2021	BlackRock Inc.	2,061,171	$23.38M	0.0%	+1,006.2%	5.557%
8/11/2021	Deutsche Bank AG	21,524	$0.24M	0.0%	N/A	0.058%
8/6/2021	Ameritas Investment Partners Inc.	2,843	$32K	0.0%	N/A	0.008%
8/6/2021	Nisa Investment Advisors LLC	3,800	$43K	0.0%	N/A	0.010%
8/6/2021	Aisling Capital Management LP	288,571	$3.27M	0.5%	N/A	0.778%
8/6/2021	Sei Investments Co.	16,908	$0.19M	0.0%	N/A	0.046%
8/5/2021	Rhumbline Advisers	30,082	$0.34M	0.0%	N/A	0.081%
8/2/2021	New York State Common Retirement Fund	31,000	$0.35M	0.0%	N/A	0.084%
6/3/2021	Hoylecohen LLC	14,000	$0.13M	0.0%	N/A	0.038%
5/19/2021	Logos Global Management LP	470,000	$4.35M	0.4%	N/A	9.084%
5/18/2021	BVF Inc. IL	3,094,174	$28.62M	1.1%	N/A	59.802%
5/18/2021	Millennium Management LLC	123,410	$1.14M	0.0%	N/A	2.385%
5/18/2021	Opaleye Management Inc.	103,600	$0.96M	0.1%	N/A	2.002%
5/18/2021	Samsara BioCapital LLC	831,625	$7.69M	1.4%	N/A	16.073%
5/18/2021	Silverarc Capital Management LLC	28,570	$0.26M	0.1%	N/A	0.552%
5/17/2021	Palo Alto Investors LP	33,212	$0.31M	0.0%	N/A	0.642%
5/17/2021	Price T Rowe Associates Inc. MD	510,000	$4.72M	0.0%	N/A	9.857%
5/17/2021	Janus Henderson Group PLC	646,820	$5.99M	0.0%	N/A	12.501%
5/17/2021	HRT Financial LP	23,826	$0.22M	0.0%	N/A	0.460%
5/17/2021	Ikarian Capital LLC	155,599	$1.44M	0.0%	N/A	3.007%
5/17/2021	Goldman Sachs Group Inc.	603,974	$5.59M	0.0%	N/A	11.673%
5/14/2021	NEA Management Company LLC	37,093	$0.34M	0.0%	N/A	0.717%
5/14/2021	Hoylecohen LLC	14,000	$0.13M	0.0%	N/A	0.271%
5/14/2021	Monashee Investment Management LLC	84,802	$0.78M	0.1%	N/A	1.639%
5/14/2021	Sectoral Asset Management Inc	647,556	$5.99M	0.5%	N/A	12.516%
5/13/2021	Citigroup Inc.	33,594	$0.31M	0.0%	N/A	0.649%
5/13/2021	Blair William & Co. IL	51,843	$0.48M	0.0%	N/A	1.002%
5/12/2021	Northern Trust Corp	13,202	$0.12M	0.0%	N/A	0.255%
5/12/2021	Geode Capital Management LLC	58,535	$0.54M	0.0%	N/A	1.131%
5/7/2021	BlackRock Inc.	186,325	$1.72M	0.0%	N/A	3.601%
5/7/2021	Sowell Financial Services LLC	4,285	$44K	0.0%	N/A	0.083%

Data available starting January 2016

Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. The company's Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. Its product pipeline also includes vecabrutinib, a clinical-stage product candidate; and VRx-510, a preclinical product candidate. The company is headquartered in Cardiff, California.

Today's Range

Now: $0.15

$0.14

$0.15

50 Day Range

MA: $0.21

$0.15

$0.26

52 Week Range

Now: $0.15

$0.13

$1.31

Volume

422,835 shs

Average Volume

493,792 shs

Market Capitalization

$6.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Who are the company insiders with the largest holdings of Viracta Therapeutics?: Viracta Therapeutics' top insider investors include:
Daniel R Chevallard (CFO)
Mark Rothera (CEO)
Lisa Rojkjaer (Insider)
Learn More about top insider investors at Viracta Therapeutics.
Who are the major institutional investors of Viracta Therapeutics?: Viracta Therapeutics' top institutional investors include:
Stonepine Capital Management LLC — 1.27%
Learn More about top institutional investors of Viracta Therapeutics stock.
Which major investors are buying Viracta Therapeutics stock?: During the last quarter, VIRX stock was bought by institutional investors including:
Stonepine Capital Management LLC